4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Alclometasone.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Alclometasone.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Alclometasone.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alclometasone.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Alclometasone.
Aldesleukin
Alclometasone may decrease the antineoplastic activities of Aldesleukin.
Advertisement
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Alclometasone.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Alclometasone.
Aluminum
The bioavailability of Alclometasone can be decreased when combined with Aluminium.
Advertisement
Aluminum Hydroxide
The bioavailability of Alclometasone can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Alclometasone can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Alclometasone can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Alclometasone is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Alclometasone.
Amiodarone
The metabolism of Alclometasone can be decreased when combined with Amiodarone.
Amphotericin B
Alclometasone may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Alclometasone may increase the hypokalemic activities of Amphotericin B.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Alclometasone is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Alclometasone.
Apalutamide
The serum concentration of Alclometasone can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Alclometasone.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Alclometasone.
Aprepitant
The serum concentration of Alclometasone can be increased when it is combined with Aprepitant.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Alclometasone.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Alclometasone.
Atazanavir
The metabolism of Alclometasone can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Alclometasone can be decreased when combined with Atomoxetine.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Alclometasone.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Alclometasone.
Azosemide
Alclometasone may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Alclometasone.
BCG Vaccine
The risk or severity of adverse effects can be increased when Alclometasone is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Alclometasone may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Alclometasone.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Alclometasone.
Bismuth Subcitrate
The bioavailability of Alclometasone can be decreased when combined with Bismuth Subcitrate.
Boceprevir
The metabolism of Alclometasone can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Alclometasone can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Alclometasone can be decreased when it is combined with Bosentan.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Alclometasone.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Alclometasone.
Bumetanide
Alclometasone may increase the hypokalemic activities of Bumetanide.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Alclometasone.
Calcium Carbonate
The bioavailability of Alclometasone can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Alclometasone can be decreased when combined with Calcium Carbonate.
Capromab Pendetide
Alclometasone may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Carbamazepine
The metabolism of Alclometasone can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Alclometasone.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Alclometasone.
Ceritinib
The serum concentration of Alclometasone can be increased when it is combined with Ceritinib.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Alclometasone.
Chlorothiazide
Alclometasone may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Alclometasone can be increased when it is combined with Chlorotrianisene.
Chlorthalidone
Alclometasone may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Alclometasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Alclometasone.
Cinoxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Cinoxacin.
Clarithromycin
The metabolism of Alclometasone can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Alclometasone can be decreased when combined with Clemastine.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Alclometasone.
Clotrimazole
The metabolism of Alclometasone can be decreased when combined with Clotrimazole.
Cobicistat
The metabolism of Alclometasone can be decreased when combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Alclometasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Alclometasone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Alclometasone.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Alclometasone.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Alclometasone.
Crizotinib
The metabolism of Alclometasone can be decreased when combined with Crizotinib.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Alclometasone.
Cyclopenthiazide
Alclometasone may increase the hypokalemic activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Alclometasone can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Alclometasone can be decreased when it is combined with Dabrafenib.
Danazol
Alclometasone may increase the fluid retaining activities of Danazol.
Darunavir
The metabolism of Alclometasone can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Alclometasone can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Alclometasone can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Alclometasone can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Alclometasone can be decreased when combined with Delavirdine.
Demecarium
The risk or severity of adverse effects can be increased when Alclometasone is combined with Demecarium.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Alclometasone.
Dienestrol
The serum concentration of Alclometasone can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Alclometasone can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Alclometasone.
Dihydroergotamine
The metabolism of Alclometasone can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Alclometasone can be decreased when combined with Diltiazem.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Alclometasone.
Distigmine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Distigmine.
Donepezil
The risk or severity of adverse effects can be increased when Alclometasone is combined with Donepezil.
Doxycycline
The metabolism of Alclometasone can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Alclometasone can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Alclometasone can be decreased when combined with Dronedarone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Alclometasone.
Echothiophate
The risk or severity of adverse effects can be increased when Alclometasone is combined with Echothiophate.
Edrophonium
The risk or severity of adverse effects can be increased when Alclometasone is combined with Edrophonium.
Enoxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Enoxacin.
Enzalutamide
The serum concentration of Alclometasone can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Alclometasone can be increased when it is combined with Equol.
Erythromycin
The metabolism of Alclometasone can be decreased when combined with Erythromycin.
Estradiol
The serum concentration of Alclometasone can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Alclometasone can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Alclometasone can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Alclometasone can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Alclometasone can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Alclometasone can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Alclometasone can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Alclometasone can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Alclometasone.
Ethacrynate
Alclometasone may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Alclometasone may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Alclometasone can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Alclometasone.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Alclometasone.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Alclometasone.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Alclometasone.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Alclometasone.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Alclometasone.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Alclometasone.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Alclometasone.
Fleroxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Alclometasone.
Fluconazole
The metabolism of Alclometasone can be decreased when combined with Fluconazole.
Flumequine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Flumequine.
Fluoxymesterone
Alclometasone may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alclometasone.
Fluvoxamine
The metabolism of Alclometasone can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Alclometasone can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Alclometasone can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Alclometasone can be increased when combined with Fosphenytoin.
Furosemide
Alclometasone may increase the hypokalemic activities of Furosemide.
Fusidate
The serum concentration of Alclometasone can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Alclometasone can be increased when it is combined with Fusidic Acid.
Galantamine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Alclometasone is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Alclometasone is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Alclometasone is combined with Gemifloxacin.
Genistein
The serum concentration of Alclometasone can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Alclometasone is combined with Ginkgo biloba.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Alclometasone.
Grepafloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Alclometasone is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Alclometasone.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Alclometasone.
Hydrochlorothiazide
Alclometasone may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Alclometasone may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Alclometasone can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Alclometasone can be decreased when it is combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alclometasone.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Alclometasone.
Idelalisib
The metabolism of Alclometasone can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Alclometasone can be decreased when combined with Imatinib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Alclometasone.
Indapamide
Alclometasone may increase the hypokalemic activities of Indapamide.
Indinavir
The metabolism of Alclometasone can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Alclometasone can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Alclometasone.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Alclometasone.
Isavuconazole
The serum concentration of Alclometasone can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Alclometasone can be decreased when combined with Isavuconazonium.
Isoflurophate
The risk or severity of adverse effects can be increased when Alclometasone is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Alclometasone.
Isradipine
The metabolism of Alclometasone can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Alclometasone can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Alclometasone can be increased when it is combined with Ivacaftor.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Alclometasone.
Ketoconazole
The metabolism of Alclometasone can be decreased when combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alclometasone.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Alclometasone.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Alclometasone.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Alclometasone.
Levofloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Alclometasone is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Alclometasone.
Lopinavir
The metabolism of Alclometasone can be decreased when combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Alclometasone.
Lovastatin
The metabolism of Alclometasone can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Alclometasone.
Luliconazole
The serum concentration of Alclometasone can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Alclometasone can be increased when combined with Lumacaftor.
Magaldrate
The bioavailability of Alclometasone can be decreased when combined with Magaldrate.
Magnesium Hydroxide
The bioavailability of Alclometasone can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Alclometasone can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Alclometasone.
Magnesium Trisilicate
The bioavailability of Alclometasone can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Alclometasone is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Alclometasone.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alclometasone.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alclometasone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alclometasone.
Mefloquine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Alclometasone.
Memantine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Alclometasone.
Mesterolone
Alclometasone may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Alclometasone can be increased when it is combined with Mestranol.
Methyclothiazide
Alclometasone may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Alclometasone.
Methyltestosterone
Alclometasone may increase the fluid retaining activities of Methyltestosterone.
Metoclopramide
The risk or severity of adverse effects can be increased when Alclometasone is combined with Metoclopramide.
Metolazone
Alclometasone may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Alclometasone can be decreased when used in combination with Mifepristone.
Minaprine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Minaprine.
Mitotane
The serum concentration of Alclometasone can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Alclometasone.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Alclometasone.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Alclometasone.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Alclometasone.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Alclometasone.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Alclometasone.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Alclometasone is combined with Nalidixic Acid.
Nandrolone
Alclometasone may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Alclometasone may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Alclometasone.
Nefazodone
The metabolism of Alclometasone can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Alclometasone can be decreased when combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Alclometasone.
Netupitant
The serum concentration of Alclometasone can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Alclometasone can be increased when combined with Nevirapine.
Nicorandil
The risk or severity of adverse effects can be increased when Alclometasone is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Alclometasone.
Nilotinib
The metabolism of Alclometasone can be decreased when combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Alclometasone.
Norfloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Alclometasone is combined with 1,10-Phenanthroline.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Alclometasone.
Olaparib
The metabolism of Alclometasone can be decreased when combined with Olaparib.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Alclometasone.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Alclometasone.
Osimertinib
The serum concentration of Alclometasone can be increased when it is combined with Osimertinib.
Oxandrolone
Alclometasone may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Alclometasone.
Oxymetholone
Alclometasone may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Alclometasone.
Palbociclib
The serum concentration of Alclometasone can be increased when it is combined with Palbociclib.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Alclometasone.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Alclometasone.
Pefloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Pefloxacin.
Pentobarbital
The metabolism of Alclometasone can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Alclometasone can be increased when combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Alclometasone.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Alclometasone.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Alclometasone.
Phenytoin
The metabolism of Alclometasone can be increased when combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Alclometasone.
Piretanide
Alclometasone may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Alclometasone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Alclometasone.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Alclometasone.
Polyestradiol Phosphate
The serum concentration of Alclometasone can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Alclometasone may increase the hypokalemic activities of Polythiazide.
Posaconazole
The metabolism of Alclometasone can be decreased when combined with Posaconazole.
Primidone
The metabolism of Alclometasone can be increased when combined with Primidone.
Promestriene
The serum concentration of Alclometasone can be increased when it is combined with Promestriene.
Pyridostigmine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Alclometasone is combined with Pyridostigmine.
Quinestrol
The serum concentration of Alclometasone can be increased when it is combined with Quinestrol.
Quinethazone
Alclometasone may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Alclometasone is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rabies virus inactivated antigen, A.
Ranolazine
The metabolism of Alclometasone can be decreased when combined with Ranolazine.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Alclometasone.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Alclometasone.
Rifabutin
The metabolism of Alclometasone can be increased when combined with Rifabutin.
Rifampin
The metabolism of Alclometasone can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Alclometasone can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Alclometasone.
Rivastigmine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Alclometasone.
Rosoxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Alclometasone is combined with Rubella virus vaccine.
Rucaparib
The metabolism of Alclometasone can be decreased when combined with Rucaparib.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Alclometasone.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Alclometasone.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Alclometasone is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Alclometasone.
Saquinavir
The metabolism of Alclometasone can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Alclometasone can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Alclometasone can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Alclometasone.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Alclometasone.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Alclometasone.
Sildenafil
The metabolism of Alclometasone can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Alclometasone can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Alclometasone can be increased when it is combined with Simeprevir.
Sodium Bicarbonate
The bioavailability of Alclometasone can be decreased when combined with Sodium bicarbonate.
Sparfloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Alclometasone can be decreased when it is combined with St. John's Wort.
Stanozolol
Alclometasone may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Alclometasone.
Sulfisoxazole
The metabolism of Alclometasone can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Alclometasone.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Alclometasone.
synthetic conjugated estrogens, A
The serum concentration of Alclometasone can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Alclometasone can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Tacrine.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Alclometasone.
Telithromycin
The metabolism of Alclometasone can be decreased when combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alclometasone.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Alclometasone.
Testosterone
Alclometasone may increase the fluid retaining activities of Testosterone.
Testosterone Cypionate
The risk or severity of edema formation can be increased when Testosterone cypionate is combined with Alclometasone.
Testosterone Enanthate
The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Alclometasone.
Testosterone Propionate
Alclometasone may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
The risk or severity of fluid retention can be increased when Testosterone undecanoate is combined with Alclometasone.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Alclometasone is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Alclometasone.
Tibolone
The serum concentration of Alclometasone can be increased when it is combined with Tibolone.
Ticlopidine
The metabolism of Alclometasone can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Alclometasone can be decreased when it is combined with Tocilizumab.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Alclometasone.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Alclometasone.
Torsemide
Alclometasone may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Alclometasone.
Trichlormethiazide
Alclometasone may increase the hypokalemic activities of Trichlormethiazide.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Alclometasone.
Tromethamine
The bioavailability of Alclometasone can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Alclometasone is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Alclometasone is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Alclometasone.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Varicella Zoster Vaccine (Live/Attenuated).
Vemurafenib
The serum concentration of Alclometasone can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Alclometasone can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Alclometasone can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Alclometasone can be decreased when combined with Voriconazole.
Warfarin
Alclometasone may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Alclometasone is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Alclometasone is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Alclometasone.
Ziprasidone
The metabolism of Alclometasone can be decreased when combined with Ziprasidone.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Alclometasone.
